Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Radzikowska, E. Wiatr, P. Remiszewski, I. Bestry, R. Langfort, I. Hawrylkiewicz, K. Roszkowski (Warsaw, Poland). Pulmonary Langerhans‘-cell histiocytosis – clinical futures and outcome. Eur Respir J 2007; 30: Suppl. 51, 551

Member's Comments

No comment yet.

Related content which might interest you: Clinical course and outcome of pulmonary Langerhans‘-cell histiocytosis Source: Annual Congress 2010 - Rare diffuse lung diseases Year: 2010 Pulmonary Langerhans histiocytosis: clinical, radiological and functional pattern in spontaneous remission Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease Year: 2009 Clinical features and outcome of adult patients with pulmonary Langerhans cell histiocytosis Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases Year: 2019 Clinical study of pulmonary hypertension complicating pulmonary Langerhans cell histiocytosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease I Year: 2012 Pulmonary histiocytosis triggered by marijuana- and nicotine-abuse Source: Eur Respir J 2002; 20: Suppl. 38, 338s Year: 2002 Special features in progress of cases with pulmonary histiocytosis X Source: Eur Respir J 2002; 20: Suppl. 38, 59s Year: 2002 Pathological findings in histiocytosis X with pulmonary hypertension Source: Annual Congress 2012 - Diffuse parenchymal lung disease IV Year: 2012 Pulmonary Langerhans‘ cell histiocytosis (PLCH). Report of two cases diagnosed with pulmonary vascular involvement via exercise tests Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease Year: 2008 Cladribine improves lung cysts and pulmonary function in a child with histiocytosis Source: Eur Respir J 2015; 45: 831-833 Year: 2015 Pulmonary hypertension in pulmonary Langerhans’ cell histiocytosis Source: Eur Respir Mon 2012; 57: 161-165 Year: 2012 Pulmonary Langerhans' cell histiocytosis Source: Eur Respir Mon; 2009: 46: 155–175 Year: 2009 Pulmonary Langerhans‘ cell histiocytosis (PLCH): A new UK register Source: Annual Congress 2012 - Cystic lung diseases: lung granulomatosis Year: 2012 Pulmonary vasculitis and malignancy - a great masquerader and diagnostic dilemma Source: International Congress 2018 – CC5 Pulmonary vasculitis: the great chameleon Year: 2018 Clinical characteristics and prognosis of chronic pulmonary aspergillosis Source: International Congress 2019 – Clinical challenges in respiratory infection Year: 2019 Langerhans’ cell granulomatosis: clinical manifestations and prognosis of pulmonary lesions Source: Eur Respir J 2004; 24: Suppl. 48, 49s Year: 2004 Smoking status and long term clinical outcome in patients with pulmonary Langerhans cell histiocytosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013 Pulmonary Langerhans cell histiocytosis Source: Annual Congress 2008 - PG5 - Interstitial lung diseases: selected orphan diseases Year: 2008 Clinical and pathological features of 13 adult patients with pulmonary Langerhans‘ cell histiocytosis Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease Year: 2009 Pulmonary Langerhans‘ cell histiocytosis Source: Eur Respir J 2006; 28: Suppl. 50, 826s Year: 2006